Menu
  • Home
  • About
  • Distributors
  • Investors
Pressure BioSciences Inc
Menu
  • Technology
  • Products
  • Publications
  • Contract Services
  • Contact

Press Releases

Investors
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Audio and Video
    • Email Alerts
  • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All Filings
    • Annual Reports
    • Proxy Statements
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

News / Events

  • Press Releases
  • IR Calendar
  • Audio and Video
  • Email Alerts

Pressure BioSciences Announces Contracted Production Launch for Estimated $3,000,000 of UST-Processed, Nanoemulsified CBD Spray for Oral Use

Jun 29, 2022

Pressure BioSciences' Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market

Jun 14, 2022

Emerging Technology Insider Releases New TechTalks Video Interview with Pressure BioSciences' CEO Richard T. Schumacher

May 24, 2022

Pressure BioSciences, Inc. Reports Q1 2022 Financial Results

May 19, 2022

Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program

May 4, 2022

Pressure BioSciences to Present at the Planet MicroCap Showcase 2022 on May 4, 2022

May 3, 2022

Pressure BioSciences Announces Early Access Program for UST Nanoemulsion Processing

Apr 27, 2022

Pressure BioSciences to Discuss Recent Achievements and Upcoming Commercialization of its Enabling UST Platform at the Sequire Cannabis & Psychedelics Conference

Apr 19, 2022

Pressure BioSciences Leveraging Strong FY2021 Operational and Financial Successes, Worldwide Customer Base, Substantial IP Estate, and Three Powerful Technology Platforms to Accelerate Strategic Company Transformation in 2022

Apr 5, 2022

Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2021 Financial Results and Provide Business Update

Apr 1, 2022
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...42

    Browse Our Site

    • Home
    • About
    • Distributors
    • Investors
    • Technology
    • Products
    • Publications
    • Contract Services
    • Contact

    Visit Us

    • Corporate Office
    • Pressure BioSciences, Inc.
    • 14 Norfolk Avenue
    • South Easton, MA 02375
    • Research & Development Laboratory
    • Pressure BioSciences, Inc.
    • Suite 1950
    • 200 Boston Avenue
    • Medford, MA 02155

    Connect With Us

    Talk To Us

    • P (508) 230.1828
    • F (508) 230.1829
    • E info@pressurebiosciences.com
    • SEND US A MESSAGE
    • Privacy Policy
    • Returns & Refunds
    • Terms & Conditions/Delivery & Shipment
    • Disclaimer

    © 2023 Pressure BioSciences, Inc. All Rights Reserved. Website by Interactive Palette